231 related articles for article (PubMed ID: 6093999)
1. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
Milas L; Hunter N; Stephens LC; Peters LJ
Cancer Res; 1984 Dec; 44(12 Pt 1):5567-9. PubMed ID: 6093999
[TBL] [Abstract][Full Text] [Related]
2. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation-induced leg contractures in mice.
Hunter N; Milas L
Cancer Res; 1983 Apr; 43(4):1630-2. PubMed ID: 6831410
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
Milas L; Hunter N; Reid BO; Thames HD
Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
[TBL] [Abstract][Full Text] [Related]
4. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
Milas L; McBride WH; Hunter N; Ito H
Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
[TBL] [Abstract][Full Text] [Related]
5. Protection against late effects of radiation by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
Grdina DJ; Carnes BA; Grahn D; Sigdestad CP
Cancer Res; 1991 Aug; 51(16):4125-30. PubMed ID: 1651155
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid against induction of altered hepatocyte foci in rats treated once with gamma-radiation within one day after birth.
Grdina DJ; Peraino C; Carnes BA; Hill CK
Cancer Res; 1985 Nov; 45(11 Pt 1):5379-81. PubMed ID: 2865003
[TBL] [Abstract][Full Text] [Related]
7. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of protective effect of aminopropylamino-ethylthiophosphate in neutron beam, gamma or X-irradiation of mice (author's transl)].
Sedlmeier H; Metzger E; Jentzsch U; Weitzenegger E
Strahlentherapie; 1981 Oct; 157(10):685-91. PubMed ID: 6272452
[TBL] [Abstract][Full Text] [Related]
9. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine.
Paunesku D; Paunesku T; Wahl A; Kataoka Y; Murley J; Grdina DJ; Woloschak GE
Int J Radiat Biol; 2008 Aug; 84(8):623-34. PubMed ID: 18661379
[TBL] [Abstract][Full Text] [Related]
10. Radioprotection of pronormoblasts and normoblasts by WR-2721.
Naruka K; Bhartiya HC
Strahlenther Onkol; 1990 Aug; 166(8):542-4. PubMed ID: 2168582
[TBL] [Abstract][Full Text] [Related]
11. Behavioral toxicity and efficacy of WR-2721 as a radioprotectant.
Bogo V; Jacobs AJ; Weiss JF
Radiat Res; 1985 Nov; 104(2 Pt 1):182-90. PubMed ID: 3001816
[TBL] [Abstract][Full Text] [Related]
12. Determination of the radioprotective effects of topical applications of MEA, WR-2721, and N-acetylcysteine on murine skin.
Verhey LJ; Sedlacek R
Radiat Res; 1983 Jan; 93(1):175-83. PubMed ID: 6296910
[TBL] [Abstract][Full Text] [Related]
13. Radioprotection of mouse colony forming units-spleen against heavy-charged particle damage by WR 2721.
Afzal SM; Ainsworth EJ
Radiat Res; 1987 Jan; 109(1):118-26. PubMed ID: 3027738
[TBL] [Abstract][Full Text] [Related]
14. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
Yuhas JM
Cancer Res; 1980 May; 40(5):1519-24. PubMed ID: 6245795
[TBL] [Abstract][Full Text] [Related]
15. Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine.
Yuhas JM
Cancer Treat Rep; 1979 Jun; 63(6):971-6. PubMed ID: 223759
[TBL] [Abstract][Full Text] [Related]
16. Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721.
Hunter NR; Guttenberger R; Milas L
Int J Radiat Oncol Biol Phys; 1992; 22(4):795-8. PubMed ID: 1312077
[TBL] [Abstract][Full Text] [Related]
17. Chromosome protection by WR-2721 and MPG-single and combination treatments.
Thomas B; Devi PU
Strahlenther Onkol; 1987 Dec; 163(12):807-10. PubMed ID: 2827332
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial of the effect of S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR-2721) (NSC 296961) on the toxicity of cyclophosphamide.
Woolley PV; Ayoob MJ; Smith FP; Dritschilo A
J Clin Oncol; 1983 Mar; 1(3):198-203. PubMed ID: 6321681
[TBL] [Abstract][Full Text] [Related]
19. Protection by WR-151327 against late-effect damage from fission-spectrum neutrons.
Grdina DJ; Wright BJ; Carnes BA
Radiat Res; 1991 Oct; 128(1 Suppl):S124-7. PubMed ID: 1924738
[TBL] [Abstract][Full Text] [Related]
20. A comparison of radioprotection from three neutron sources and 60Co by WR-2721 and WR-151327.
Sigdestad CP; Grdina DJ; Connor AM; Hanson WR
Radiat Res; 1986 May; 106(2):224-33. PubMed ID: 3010368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
